Citi Downgrades ResMed (RMD:AU) (RMD) to Neutral
Tweet
Share
E-mailGet Alerts RMD:AU Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 13
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 13
Join SI Premium – FREE
Citi analyst Mathieu Chevrier downgraded ResMed (RMD:AU) (NYSE: RMD) from Buy to Neutral with a price target of AUD37.50 (from AUD38.50).
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Hapag-Lloyd AG (HLAG:GR) (HLAGF) to Reduce
- Berenberg Downgrades M&G PLC (MNG:LN) to Hold
- UBS Downgrades Nokia OYJ (NOKIA:FH) (NOK) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
